A revolutionary pancreatic cancer drug in late-stage clinical trials is extending the life of former Sen. Ben Sasse, but it is also causing painful skin side effects.
Sasse, who retired from politics in 2023 to become the president of the University of Florida, was diagnosed in December 2025 with advanced pancreatic cancer, the third most deadly form of cancer in the United States according to the National Cancer Institute.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.